These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24412114)
1. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Hodge JC; Pearce KE; Clayton AC; Taran FA; Stewart EA Am J Obstet Gynecol; 2014 Jun; 210(6):572.e1-7. PubMed ID: 24412114 [TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Christacos NC; Quade BJ; Dal Cin P; Morton CC Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247 [TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Levy B; Mukherjee T; Hirschhorn K Cancer Genet Cytogenet; 2000 Aug; 121(1):1-8. PubMed ID: 10958933 [TBL] [Abstract][Full Text] [Related]
4. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Xing YP; Powell WL; Morton CC Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121 [TBL] [Abstract][Full Text] [Related]
5. Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature. McDonald AG; Dal Cin P; Ganguly A; Campbell S; Imai Y; Rosenberg AE; Oliva E Am J Surg Pathol; 2011 Feb; 35(2):221-7. PubMed ID: 21263242 [TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043 [TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hodge JC; Morton CC Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550 [TBL] [Abstract][Full Text] [Related]
9. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592 [TBL] [Abstract][Full Text] [Related]
10. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407 [TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Moore SD; Herrick SR; Ince TA; Kleinman MS; Dal Cin P; Morton CC; Quade BJ Cancer Res; 2004 Aug; 64(16):5570-7. PubMed ID: 15313893 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient. Dimitrova IK; Richer JK; Rudolph MC; Spoelstra NS; Reno EM; Medina TM; Bradford AP Fertil Steril; 2009 Jun; 91(6):2650-63. PubMed ID: 18672237 [TBL] [Abstract][Full Text] [Related]
14. Translocations in 7q22 define a critical region in uterine leiomyomata. Sargent MS; Weremowicz S; Rein MS; Morton CC Cancer Genet Cytogenet; 1994 Oct; 77(1):65-8. PubMed ID: 7923086 [TBL] [Abstract][Full Text] [Related]
15. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Wei JJ; Chiriboga L; Mittal K Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893 [TBL] [Abstract][Full Text] [Related]
16. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Hennig Y; Deichert U; Bonk U; Thode B; Bartnitzke S; Bullerdiek J Mol Hum Reprod; 1999 Dec; 5(12):1150-4. PubMed ID: 10587370 [TBL] [Abstract][Full Text] [Related]
17. PCOLCE deletion and expression analyses in uterine leiomyomata. Ligon AH; Scott IC; Takahara K; Greenspan DS; Morton CC Cancer Genet Cytogenet; 2002 Sep; 137(2):133-7. PubMed ID: 12393284 [TBL] [Abstract][Full Text] [Related]
18. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Schoenberg Fejzo M; Ashar HR; Krauter KS; Powell WL; Rein MS; Weremowicz S; Yoon SJ; Kucherlapati RS; Chada K; Morton CC Genes Chromosomes Cancer; 1996 Sep; 17(1):1-6. PubMed ID: 8889500 [TBL] [Abstract][Full Text] [Related]
19. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Dundr P; Gregová M; Hojný J; Krkavcová E; Michálková R; Němejcová K; Bártů M; Hájková N; Laco J; Mára M; Richtárová A; Zima T; Stružinská I Virchows Arch; 2022 Feb; 480(2):281-291. PubMed ID: 34626221 [TBL] [Abstract][Full Text] [Related]
20. Chromosome 7 biclonality in uterine leiomyoma. Ozisik YY; Meloni AM; Powell M; Surti U; Sandberg AA Cancer Genet Cytogenet; 1993 May; 67(1):59-64. PubMed ID: 8504401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]